Kremer B - Search Results

1

Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.

Schmiegel W, Schmielau J, Henne-Bruns D, Juhl H, Roeder C, Buggisch P, Onur A, Kremer B, Kalthoff H, Jensen EV. Schmiegel W, et al. Among authors: kremer b. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12622-6. doi: 10.1073/pnas.94.23.12622. Proc Natl Acad Sci U S A. 1997. PMID: 9356499 Free PMC article.

2

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.

Juhl H, Helmig F, Baltzer K, Kalthoff H, Henne-Bruns D, Kremer B. Juhl H, et al. Among authors: kremer b. J Surg Oncol. 1997 Mar;64(3):222-30. doi: 10.1002/(sici)1096-9098(199703)64:3<222::aid-jso9>3.0.co;2-c. J Surg Oncol. 1997. PMID: 9121154

3

[Initial results of combined surgical-medical therapy for metastatic cancer of the stomach].

Henne-Bruns D, Kremer B, Weh HJ. Henne-Bruns D, et al. Among authors: kremer b. Helv Chir Acta. 1990 Jun;57(1):73-6. Helv Chir Acta. 1990. PMID: 1699913 German.

4

Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.

Marxsen J, Schmiegel W, Röder C, Harder R, Juhl H, Henne-Bruns D, Kremer B, Kalthoff H. Marxsen J, et al. Among authors: kremer b. Br J Cancer. 1994 Nov;70(5):1031-4. doi: 10.1038/bjc.1994.443. Br J Cancer. 1994. PMID: 7947080 Free PMC article.

5

Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients.

Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener C, Schreiber HW, Kalthoff H. Juhl H, et al. Among authors: kremer b. Int J Cancer. 1994 May 1;57(3):330-5. doi: 10.1002/ijc.2910570307. Int J Cancer. 1994. PMID: 8168992

6

Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H. Ungefroren H, et al. Among authors: kremer b. Cancer Res. 1998 Apr 15;58(8):1741-9. Cancer Res. 1998. PMID: 9563493

7

A human carcinoma model in athymic rats reflecting solid and disseminated colorectal metastases.

Vogel I, Shen Y, Soeth E, Juhl H, Kremer B, Kalthoff H, Henne-Bruns D. Vogel I, et al. Among authors: kremer b. Langenbecks Arch Surg. 1998 Dec;383(6):466-73. doi: 10.1007/s004230050162. Langenbecks Arch Surg. 1998. PMID: 9921949

8

Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor.

Vogel I, Krüger U, Marxsen J, Soeth E, Kalthoff H, Henne-Bruns D, Kremer B, Juhl H. Vogel I, et al. Among authors: kremer b. Clin Cancer Res. 1999 Mar;5(3):593-9. Clin Cancer Res. 1999. PMID: 10100711

9

Immunological escape mechanisms in pancreatic carcinoma.

Ungefroren H, Voss M, Bernstorff WV, Schmid A, Kremer B, Kalthoff H. Ungefroren H, et al. Among authors: kremer b. Ann N Y Acad Sci. 1999 Jun 30;880:243-51. doi: 10.1111/j.1749-6632.1999.tb09529.x. Ann N Y Acad Sci. 1999. PMID: 10415870

10

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer.

Graeven U, Kremer B, Südhoff T, Killing B, Rojo F, Weber D, Tillner J, Unal C, Schmiegel W. Graeven U, et al. Among authors: kremer b. Br J Cancer. 2006 May 8;94(9):1293-9. doi: 10.1038/sj.bjc.6603083. Br J Cancer. 2006. PMID: 16622465 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters